Join ARMI at Cell & Gene Therapy International during Biotech Week Boston, where Chief Regulatory Officer Dr. Richard McFarland will moderate a panel on decentralized manufacturing for cell therapies.
ARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry's leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
Over the course of a single day, the ARMI Investment Summit will connect founders, investors, commercialization experts, manufacturers, and industry leaders to accelerate innovation through expert panel discussions, the BioFab Startup Lab Pitch Competition, and meaningful networking opportunities.
ARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
